Glaxo Sues Spectrum Pharma Over Imitrex Patent Challenge
GlaxoSmithKline has sued specialty drug maker Spectrum Pharmaceuticals, Inc. over its challenge to Glaxo's patent for the migraine injection treatment Imitrex....To view the full article, register now.
Already a subscriber? Click here to view full article